Jean-Christophe Renondin, Board member

  • 2008

    27 November 2008:  Announcement no. 3, 2008: Zealand Pharma and Helsinn Healthcare S...

    Read More >

  • Product Pipeline

    Zealand's Pipeline comprises 1 compound in phase III, 1 compound in phase II, 2 c...

    Read More >

Jean-Christophe Renondin, Board member

Board member since 2006. Mr. Renondin holds a Medical Degree from Paris specialising in Medical Biology (clinical pharmacology) as well as an MBA from Dartmouth University in New Hampshire. Mr. Renondin is general partner of CDC Innovation, Paris, which he joined in 2005. Within the past years, Mr. Renondin has held positions as Managing Director at MDS Capital, USA, Vice President of Sofinov (Societe Financiere d'Innovation), a subsidiary of The Caisse de Depot et Placement du Quebec, General Manager in the Pharmaceutical Group Servier, and an Associate at JP Morgan Bank.

 

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.



Related links